Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

"MEGAS": Mitochondrial Encephalopathy, Gastric Dysmotility, and Seizures
Child Neurology and Developmental Neurology
P15 - Poster Session 15 (12:00 PM-1:00 PM)
5-015
To describe the association of a trio of mitochondrial gene mutations to a clinical phenotype of adult-onset mitochondrial disease.

Mitochondrial diseases are a group of disorders that primarily present during infancy with variable phenotypes.  While still rare, mitochondrial disease can present with stroke like episodes, lactic acidosis, deafness, diabetes mellitus, short stature, and myopathy, usually in association with a family history with maternal inheritance.  

Case Report

We report a case of mitochondrial disease in a formerly healthy 53-year-old male who presented with seizures and encephalopathy after an exploratory laparotomy for a small bowel obstruction.  His history was significant for hearing loss and suggestive of gastric dysmotility. The patient’s clinical course was characterized by status epilepticus requiring a prolonged NCCU stay.  Initial MRI suggested an acute cerebellar CVA. Subsequent imaging studies showed extensive bicortical and subcortical diffusion restriction.  After an extensive workup, the patient was found to have 3 mitochondrial gene variants not previously described in a single patient: MT-TA, MT-TV, and MT-TS1.  The patient was started on L-carnitine and coenzyme Q10 supplementation and his potentially mitochondriotoxic medications, phenobarbital and phenytoin, were discontinued. Ultimately, he stabilized with seizure control and there was no further radiographic progression. However, clinically, he was unchanged and was discharged to a skilled nursing facility in an unresponsive state.

To our knowledge, this is the first case report of these three mitochondrial mutations associated with new CVA and status epilepticus.  The MT-TA mutation has been described previously as causing myopathic presentations, but has not been associated with seizures or acute CVA.  The MT-TV mutation has not been previously reported, while the MT-TS1 has been reported but is of unknown significance.  This may suggest pathogenicity of the two lesser described variants, but further functional studies on these variants will need to be done before confirming this.  
Authors/Disclosures
Marika Antimisiaris, MD (The Ohio State University)
PRESENTER
Dr. Antimisiaris has nothing to disclose.
Mark E. Pierce, MD Dr. Pierce has nothing to disclose.
Bryan M. Gough, MD (Ohio State University) No disclosure on file